• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向蛋白质修饰:胰腺癌免疫治疗的新方向。

Targeting protein modification: a new direction for immunotherapy of pancreatic cancer.

作者信息

Ge Xinyu, Zhang Ke, Zhu Jie, Chen Yuan, Wang Zhengwang, Wang Peng, Xu Peng, Yao Jie

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Jiangsu 225000, China.

The Yangzhou School of Clinical Medicine of Dalian Medical University, Jiangsu 225000, China.

出版信息

Int J Biol Sci. 2025 Jan 1;21(1):63-74. doi: 10.7150/ijbs.101861. eCollection 2025.

DOI:10.7150/ijbs.101861
PMID:39744438
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11667816/
Abstract

Post-translational modifications (PTMs) alter protein conformation by covalently attaching functional groups to substrates, influencing their biological activity, mechanisms of action, and functional performance. PTMs and their interactions are essential to many critical signal transduction processes, including tumor transformation, cancer progression, and metastasis in pancreatic cancer. Additionally, advancements in tumor immunotherapy indicate that PTMs are essential in immune cell activation, transport, and energy metabolism. This study aimed to investigate the effects of different PTMs on immunotherapy for pancreatic cancer, providing new perspectives and suggesting directions for future research.

摘要

翻译后修饰(PTMs)通过将官能团共价连接到底物上来改变蛋白质构象,影响其生物学活性、作用机制和功能表现。PTMs及其相互作用对于许多关键的信号转导过程至关重要,包括胰腺癌中的肿瘤转化、癌症进展和转移。此外,肿瘤免疫疗法的进展表明,PTMs在免疫细胞激活、运输和能量代谢中至关重要。本研究旨在探讨不同PTMs对胰腺癌免疫治疗的影响,为未来研究提供新的视角并指明方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e482/11667816/cbae14714371/ijbsv21p0063g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e482/11667816/b8320da23cc4/ijbsv21p0063g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e482/11667816/d5d54a3bbf9a/ijbsv21p0063g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e482/11667816/cbae14714371/ijbsv21p0063g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e482/11667816/b8320da23cc4/ijbsv21p0063g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e482/11667816/d5d54a3bbf9a/ijbsv21p0063g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e482/11667816/cbae14714371/ijbsv21p0063g003.jpg

相似文献

1
Targeting protein modification: a new direction for immunotherapy of pancreatic cancer.靶向蛋白质修饰:胰腺癌免疫治疗的新方向。
Int J Biol Sci. 2025 Jan 1;21(1):63-74. doi: 10.7150/ijbs.101861. eCollection 2025.
2
Advances in post-translational modifications of proteins and cancer immunotherapy.蛋白质翻译后修饰与癌症免疫治疗的新进展。
Front Immunol. 2023 Aug 22;14:1229397. doi: 10.3389/fimmu.2023.1229397. eCollection 2023.
3
Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.免疫治疗胰腺癌的困境与挑战。
Dig Dis Sci. 2021 Feb;66(2):359-368. doi: 10.1007/s10620-020-06183-9. Epub 2020 Mar 5.
4
Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy.肝细胞癌中的翻译后修饰:开启免疫治疗的新前沿
Front Immunol. 2025 Feb 18;16:1554372. doi: 10.3389/fimmu.2025.1554372. eCollection 2025.
5
Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy.PD-L1 翻译后修饰的调控与肿瘤免疫治疗的进展。
Front Immunol. 2023 Jul 24;14:1230135. doi: 10.3389/fimmu.2023.1230135. eCollection 2023.
6
Novel post-translational modifications of protein by metabolites with immune responses and immune-related molecules in cancer immunotherapy.代谢物对蛋白质的新型翻译后修饰与癌症免疫治疗中的免疫反应和免疫相关分子。
Int J Biol Macromol. 2024 Oct;277(Pt 1):133883. doi: 10.1016/j.ijbiomac.2024.133883. Epub 2024 Jul 19.
7
Role of UFMylation in tumorigenesis and cancer immunotherapy.泛素样修饰物在肿瘤发生和癌症免疫治疗中的作用。
Front Immunol. 2024 Aug 23;15:1454823. doi: 10.3389/fimmu.2024.1454823. eCollection 2024.
8
Complex role for the immune system in initiation and progression of pancreatic cancer.免疫系统在胰腺癌起始和进展中的复杂作用。
World J Gastroenterol. 2014 Aug 28;20(32):11160-81. doi: 10.3748/wjg.v20.i32.11160.
9
Characterization of histone-related chemical modifications in formalin-fixed paraffin-embedded and fresh-frozen human pancreatic cancer xenografts using LC-MS/MS.利用液相色谱-串联质谱法对福尔马林固定石蜡包埋及新鲜冷冻的人胰腺癌异种移植瘤中组蛋白相关化学修饰进行表征。
Lab Invest. 2017 Mar;97(3):279-288. doi: 10.1038/labinvest.2016.134. Epub 2016 Dec 12.
10
Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets.胰腺导管腺癌细胞重塑免疫微环境:分子机制与治疗靶点。
Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189183. doi: 10.1016/j.bbcan.2024.189183. Epub 2024 Sep 18.

引用本文的文献

1
thermal-responsive hydrogels for combined photothermal therapy and chemotherapy of pancreatic cancer.用于胰腺癌光热疗法和化疗联合治疗的热响应水凝胶
RSC Adv. 2025 Apr 24;15(17):13119-13126. doi: 10.1039/d5ra00371g. eCollection 2025 Apr 22.

本文引用的文献

1
Deciphering the SOX4/MAPK1 regulatory axis: a phosphoproteomic insight into IQGAP1 phosphorylation and pancreatic Cancer progression.解析 SOX4/MAPK1 调控轴:IQGAP1 磷酸化和胰腺癌进展的磷酸化蛋白质组学见解。
J Transl Med. 2024 Jun 28;22(1):602. doi: 10.1186/s12967-024-05377-3.
2
N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearance.Mgat5 的 N-糖基化对免疫介导的肿瘤清除施加了可靶向的限制。
JCI Insight. 2024 May 23;9(12):e178804. doi: 10.1172/jci.insight.178804.
3
Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients.
联合 JAK 抑制和 PD-1 免疫疗法治疗非小细胞肺癌患者。
Science. 2024 Jun 21;384(6702):eadf1329. doi: 10.1126/science.adf1329.
4
DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer.DYRK1B 阻断促进胰腺癌中的肿瘤杀伤性巨噬细胞活性。
Gut. 2024 Sep 9;73(10):1684-1701. doi: 10.1136/gutjnl-2023-331854.
5
FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis.FBXO32 通过刺激蛋白质合成促进胰腺癌的进展和转移。
Cancer Res. 2024 Aug 15;84(16):2607-2625. doi: 10.1158/0008-5472.CAN-23-3638.
6
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
7
EZH2 Inhibition Enhances PD-L1 Protein Stability Through USP22-Mediated Deubiquitination in Colorectal Cancer.EZH2 抑制通过 USP22 介导的去泛素化增强结直肠癌中的 PD-L1 蛋白稳定性。
Adv Sci (Weinh). 2024 Jun;11(23):e2308045. doi: 10.1002/advs.202308045. Epub 2024 Mar 22.
8
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2 Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy.用硝呋替莫靶向 ESE3/EHF 抑制 CXCR2 中性粒细胞浸润并克服胰腺癌对化疗和免疫治疗的耐药性。
Gastroenterology. 2024 Jul;167(2):281-297. doi: 10.1053/j.gastro.2024.02.046. Epub 2024 Mar 15.
9
USP22 supports the aggressive behavior of basal-like breast cancer by stimulating cellular respiration.USP22 通过刺激细胞呼吸来支持基底样乳腺癌的侵袭性行为。
Cell Commun Signal. 2024 Feb 12;22(1):120. doi: 10.1186/s12964-023-01441-5.
10
ASPP2 Is Phosphorylated by CDK1 during Mitosis and Required for Pancreatic Cancer Cell Proliferation.ASPP2在有丝分裂期间被CDK1磷酸化,是胰腺癌细胞增殖所必需的。
Cancers (Basel). 2023 Nov 15;15(22):5424. doi: 10.3390/cancers15225424.